Tianjin TEDA Biomedical Engineering Company Limited
Tianjin TEDA Biomedical Engineering Company Limited (HKSE: 8189) is trading at HK$0.26, about ₹3 at today's HKD/INR rate, as of 24 Sep 2026, 4:08 AM ET. Indian residents can buy Tianjin TEDA Biomedical Engineering from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.25
Today's high
HK$0.26
52 week low
HK$0.11
52 week high
HK$0.43
8189 opened at HK$0.26, closed previously at HK$0.26, and has traded between HK$0.11 and HK$0.43 over the past 52 weeks.
About
Tianjin TEDA Biomedical Engineering Company Limited, founded in 2000 and based in Tianjin, People's Republic of China, is a diversified enterprise primarily involved in the research, development, manufacturing, and distribution of biological compound fertilizer products throughout the PRC. Its operations are organized into two main divisions: Biological Compound Fertilizers and Elderly and Health Care Services. The company's agricultural offerings encompass active fertilizers and various tailored blends of nitrogen, phosphorus, and potassium, specifically formulated to promote balanced growth for a range of crops including grains, fruits, and vegetables. Beyond agriculture, Tianjin TEDA Biomedical provides integrated care for the elderly and comprehensive health services. This includes leasing essential equipment for seniors and offering specialized consulting, advisory, and assessment solutions. Furthermore, the company develops and licenses electroencephalography (EEG) diagnosis detection services, utilizing its expertise in EEG technology for diagnostic applications. Its extensive activities also cover the research, development, production, and practical application of biomedical science and technology projects, alongside regional soil resource conditioning and remediation, and the provision of soil environmental quality standards research services.
Key statistics
Avg. volume
976.19K
Market cap
HK$554.81M
P/E Ratio
-16.10
Price-to-sales ratio
0.56
Enterprise value
CN¥517.54M
Free cash flow yield
8.10%
Debt-to-equity ratio
4.85
Return on equity
-329.69%
ROIC
-19.87%
Beta
-0.44
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥509.43M
Earnings per share
-CN¥0.04
Free cash flow
-CN¥62.84M
Net profit margin
-13.97%
Gross margin
7.20%
EBITDA
-CN¥14.32M
Revenue growth
32.15%
Similar securities
This is not an investment recommendation
How to buy Tianjin TEDA Biomedical Engineering from India
Indian residents can buy Tianjin TEDA Biomedical Engineering shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Tianjin TEDA Biomedical Engineering and place an order
Find Tianjin TEDA Biomedical Engineering by name or by its ticker, 8189, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Tianjin TEDA Biomedical Engineering trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Tianjin TEDA Biomedical Engineering position in HKD and INR. Tianjin TEDA Biomedical Engineering pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Tianjin TEDA Biomedical Engineering from India
Trading and taxes when buying Tianjin TEDA Biomedical Engineering from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTianjin TEDA Biomedical Engineering does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Tianjin TEDA Biomedical Engineering stock?
Yes. Tianjin TEDA Biomedical Engineering (8189) has been listed on the Hong Kong Stock Exchange since 2002, in the Agricultural Inputs industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Tianjin TEDA Biomedical Engineering share cost in rupees?
One Tianjin TEDA Biomedical Engineering share is HK$0.26 — about ₹3 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Tianjin TEDA Biomedical Engineering price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Tianjin TEDA Biomedical Engineering from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Tianjin TEDA Biomedical Engineering?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Tianjin TEDA Biomedical Engineering shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Tianjin TEDA Biomedical Engineering price. Paasa issues a capital-gains statement for your return.
Does Tianjin TEDA Biomedical Engineering pay a dividend?
No. Tianjin TEDA Biomedical Engineering does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Tianjin TEDA Biomedical Engineering from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Tianjin TEDA Biomedical Engineering a Hong Kong SAR China company, and does that change how it is taxed?
Tianjin TEDA Biomedical Engineering trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Tianjin TEDA Biomedical Engineering trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Tianjin TEDA Biomedical Engineering shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Tianjin TEDA Biomedical Engineering holding, its cost and its closing value.
How do I sell Tianjin TEDA Biomedical Engineering and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.